Clinical Trial Update: Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the efficacy and safety of Linperlisib in relapsed or refractory T-cell large granular lymphocytic leukemia, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• Linperlisib (linperlisib)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Relapsed/Refractory Large Granular T Lymphocytic Leukemia | Phase 2 | Status: RECRUITING